Markers of viability and endpoints in ischemic cardiomyopathy.

被引：0
|
作者：
Amanullah, AM [1 ]
Narula, J [1 ]
Dawson, S [1 ]
Guillo, P [1 ]
Heo, J [1 ]
Iskandrian, AE [1 ]
机构：
[1] Hahnemann Univ Hosp, Philadelphia, PA 19102 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 1999年 / 40卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
738
引用
收藏
页码：162P / 162P
页数：1
相关论文
共 50 条
  • [31] Apical hypertrophic cardiomyopathy.
    Tremeau, G
    Aupetit, JF
    Buttard, P
    Chapon, P
    Milon, H
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1996, 89 (10): : 1283 - 1289
  • [32] Myocardial feature tracking for viability assessment in ischemic cardiomyopathy
    Andreas Schuster
    Matthias Paul
    Nuno Bettencourt
    Tarique Hussain
    Dirk Lossnitzer
    Masaki Ishida
    Amedeo Chiribiri
    Boris Bigalke
    Geraint Morton
    Divaka Perera
    Gerald Greil
    Eike Nagel
    Journal of Cardiovascular Magnetic Resonance, 13 (Suppl 1)
  • [33] Evaluation of myocardial viability in chronic ischemic cardiomyopathy - Response
    Bax, JJ
    van der Wall, EE
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2003, 19 (02) : 137 - 140
  • [34] Immunotherapy releated cardiomyopathy.
    Sonmez, Ozlem
    Sever, Ozlem Nuray
    Oyan, Basak
    Demir, Osman Gokhan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [35] Eosinophilic obliterative cardiomyopathy.
    Friedman, M. L.
    Siu, K.
    Catanzaro, J. N.
    Makaryus, J. N.
    Chaudhry, S.
    Ahn, J.
    Green, S.
    Boxt, L. M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (08) : 31F - 31F
  • [36] Metabolic and endothelial effects of trimetazidine in type 2 diabetic patients with ischemic dilated cardiomyopathy.
    Monti, LD
    Fragasso, G
    Setola, E
    Palloshi, A
    Camisasca, R
    Valsecchi, G
    Lucotti, P
    Pozza, G
    Piatti, PM
    DIABETOLOGIA, 2001, 44 : A69 - A69
  • [37] Incessant "ventricular tachycardia" in a patient with non-ischemic cardiomyopathy. What is the tachycardia mechanism?
    Arora, Sandeep
    JOURNAL OF ELECTROCARDIOLOGY, 2015, 48 (03) : 455 - 457
  • [38] Scintigraphic predictors of cardiac resynchronization therapy efficacy in patients with non-ischemic cardiomyopathy.
    Gulya, Marina
    Zavadovsky, Konstantin
    Lebedev, Denis
    Lishmanov, Yuriy
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [39] Pheochromocytoma-induced cardiomyopathy.
    Dale, D
    Matthews, V
    Gomez-Sanchez, C
    JOURNAL OF INVESTIGATIVE MEDICINE, 2006, 54 (01) : S257 - S257
  • [40] Viability predicts response to cardiac resynchronization therapy in ischemic cardiomyopathy
    Ypenburg, C.
    Schalij, M. J.
    Bleeker, G. B.
    Steendijk, P.
    Dibbets-Schneider, P.
    Stokkel, M. P. M.
    Van Der Wall, E. E.
    Bax, J. J.
    EUROPEAN HEART JOURNAL, 2006, 27 : 175 - 175
12345